Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease

by Paul Roderick, Julie Parkes, Theresa Hydes, Ryan Buchanan, Oliver J Kennedy, Simon Fraser
Published 2020-09-01

All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study

by Oliver J. Kennedy, Jonathan A. Fallowfield, Robin Poole, Peter C. Hayes, Julie Parkes, Paul J. Roderick
Published 2021-06-01